Institutional Ownership Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT). We have compiled data on the 254 institutions that hold shares in the stock, with a total of 127 Million shares, which have been reported (via 13F filing form) to have a value of $3.18 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jennison Associates LLC
|
Oct 30, 2025 Q3 2025 |
12,254,119
shares
|
$306 Million
0.14% of portfolio
|
Q3 2025
Added 10.3%
|
|
|
Rubric Capital Management LP
New York, NY |
Nov 14, 2025 Q3 2025 |
10,749,457
shares
|
$269 Million
3.33% of portfolio
|
Q2 2025
Reduced 1.98%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
10,478,000
shares
|
$262 Million
5.93% of portfolio
|
Q3 2025
Reduced 9.17%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 14, 2025 Q3 2025 |
9,874,511
shares
|
$247 Million
7.87% of portfolio
|
Q2 2025
Added 12.4%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,622,618
shares
|
$216 Million
0.0% of portfolio
|
Q2 2024
Added 29.49%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
7,146,090
shares
|
$179 Million
0.0% of portfolio
|
Q3 2025
Added 1.38%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
5,298,754
shares
|
$132 Million
0.54% of portfolio
|
Q3 2025
Added 5.84%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
4,641,315
shares
|
$116 Million
0.0% of portfolio
|
Q3 2025
Added 2.53%
|
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
4,429,108
shares
|
$111 Million
0.99% of portfolio
|
Q3 2025
Added 6.58%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
4,276,394
shares
|
$107 Million
0.01% of portfolio
|
Q3 2025
Reduced 0.88%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
2,948,438
shares
|
$73.7 Million
0.01% of portfolio
|
Q3 2025
Added 0.36%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
2,606,465
shares
|
$65.2 Million
0.0% of portfolio
|
Q3 2025
Added 0.93%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
2,398,031
shares
|
$60 Million
0.02% of portfolio
|
Q3 2025
Added 5.92%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
2,311,019
shares
|
$57.8 Million
0.01% of portfolio
|
Q3 2025
Reduced 15.43%
|
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
2,120,508
shares
|
$53 Million
36.11% of portfolio
|
Q3 2024
Added 3.89%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
2,118,713
shares
|
$53 Million
0.03% of portfolio
|
Q3 2025
Reduced 2.05%
|
|
|
Perpetual LTD
Sydney, New South Wales, C3 |
Oct 10, 2025 Q3 2025 |
2,024,606
shares
|
$50.6 Million
0.47% of portfolio
|
Q3 2025
Added 7534.26%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 13, 2025 Q3 2025 |
1,993,055
shares
|
$49.8 Million
0.06% of portfolio
|
Q3 2025
Added 0.23%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
1,804,988
shares
|
$45.1 Million
0.0% of portfolio
|
Q3 2025
Reduced 4.51%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2025 Q3 2025 |
1,662,470
shares
|
$41.6 Million
0.02% of portfolio
|
Q3 2025
Reduced 3.59%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
1,370,356
shares
|
$34.3 Million
0.01% of portfolio
|
Q3 2025
Added 79.0%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,327,029
shares
|
$33.2 Million
0.02% of portfolio
|
Q2 2023
Reduced 19.87%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
1,172,041
shares
|
$29.3 Million
0.2% of portfolio
|
Q3 2025
Reduced 14.97%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,097,004
shares
|
$27.4 Million
0.18% of portfolio
|
Q3 2025
Added 1.02%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
999,434
shares
|
$25 Million
0.0% of portfolio
|
Q3 2025
Added 3.56%
|
|